Skip to main content
Journal cover image

Serological response following re-vaccination with Salmonella typhi Vi-capsular polysaccharide vaccines in healthy adult travellers.

Publication ,  Journal Article
Roggelin, L; Vinnemeier, CD; Fischer-Herr, J; Johnson-Weaver, BT; Rolling, T; Burchard, GD; Staats, HF; Cramer, JP
Published in: Vaccine
August 7, 2015

An injectable Vi-capsular polysaccharide vaccine against typhoid fever is available but vaccine-induced immunity tends to wane over time. The phenomenon of immunotolerance or hyporesponsiveness has earlier been described for polysaccharide vaccines such as pneumococcal capsular polysaccharide vaccine and some publications also suggest a possible immunotolerance after revaccination with Vi-capsular polysaccharide vaccines. In this study, post-immunisation antibody concentrations in adult travellers first vaccinated with a Salmonella typhi Vi-capsular polysaccharide vaccine (primary vaccination group) were compared with those having received one or more vaccinations previously (multiple vaccinations group). Vaccines administered were Typherix(®) (GlaxoSmithKline), Typhim Vi(®) (Sanofi Pasteur MSD) or Hepatyrix(®) (GlaxoSmithKline). Blood samples were obtained prior to vaccination (day 0) and on day 28 (-1/+14) after vaccination. Serum Vi-Antigen IgG concentrations were measured by ELISA. Of the 85 subjects included in the per protocol data set, 45 (53%) belonged to the multiple vaccinations group. In both groups, geometric mean antibody concentrations (GMCs) were significantly higher after vaccination than before vaccination. Pre-vaccination GMCs were lower in the primary vaccination group than in the multiple vaccinations group (3.40 μg/ml versus 6.13 μg/ml, P=0.005), while there was no significant difference in the post vaccination GMCs between groups (11.34 μg/ml versus 14.58 μg/ml, P=0.4). In the multiple vaccinations group, vaccination was performed 18 to 57 months after the last vaccination (median 38 months) and there was a negative correlation between time since last vaccination and antibody concentration on day 0. In conclusion, we were not able to demonstrate a relevant immunotolerance after multiple versus primary vaccination with S. typhi Vi-capsular polysaccharide vaccines.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Vaccine

DOI

EISSN

1873-2518

Publication Date

August 7, 2015

Volume

33

Issue

33

Start / End Page

4141 / 4145

Location

Netherlands

Related Subject Headings

  • Young Adult
  • Virology
  • Travel
  • Salmonella Vaccines
  • Polysaccharides, Bacterial
  • Middle Aged
  • Male
  • Immunologic Memory
  • Immunoglobulin G
  • Immunization, Secondary
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Roggelin, L., Vinnemeier, C. D., Fischer-Herr, J., Johnson-Weaver, B. T., Rolling, T., Burchard, G. D., … Cramer, J. P. (2015). Serological response following re-vaccination with Salmonella typhi Vi-capsular polysaccharide vaccines in healthy adult travellers. Vaccine, 33(33), 4141–4145. https://doi.org/10.1016/j.vaccine.2015.05.080
Roggelin, Louise, Christof D. Vinnemeier, Johanna Fischer-Herr, Brandi T. Johnson-Weaver, Thierry Rolling, Gerd D. Burchard, Herman F. Staats, and Jakob P. Cramer. “Serological response following re-vaccination with Salmonella typhi Vi-capsular polysaccharide vaccines in healthy adult travellers.Vaccine 33, no. 33 (August 7, 2015): 4141–45. https://doi.org/10.1016/j.vaccine.2015.05.080.
Roggelin L, Vinnemeier CD, Fischer-Herr J, Johnson-Weaver BT, Rolling T, Burchard GD, et al. Serological response following re-vaccination with Salmonella typhi Vi-capsular polysaccharide vaccines in healthy adult travellers. Vaccine. 2015 Aug 7;33(33):4141–5.
Roggelin, Louise, et al. “Serological response following re-vaccination with Salmonella typhi Vi-capsular polysaccharide vaccines in healthy adult travellers.Vaccine, vol. 33, no. 33, Aug. 2015, pp. 4141–45. Pubmed, doi:10.1016/j.vaccine.2015.05.080.
Roggelin L, Vinnemeier CD, Fischer-Herr J, Johnson-Weaver BT, Rolling T, Burchard GD, Staats HF, Cramer JP. Serological response following re-vaccination with Salmonella typhi Vi-capsular polysaccharide vaccines in healthy adult travellers. Vaccine. 2015 Aug 7;33(33):4141–4145.
Journal cover image

Published In

Vaccine

DOI

EISSN

1873-2518

Publication Date

August 7, 2015

Volume

33

Issue

33

Start / End Page

4141 / 4145

Location

Netherlands

Related Subject Headings

  • Young Adult
  • Virology
  • Travel
  • Salmonella Vaccines
  • Polysaccharides, Bacterial
  • Middle Aged
  • Male
  • Immunologic Memory
  • Immunoglobulin G
  • Immunization, Secondary